NASDAQ:GLMD | Free Cash Flow | Galmed Pharmaceuticals Ltd.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$1.95M
2024-12-31-$1.91M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$6.32M
2024-12-31-$5.88M
2023-12-31-$6.14M
2022-12-31-$18.5M$4,000.00-$18.51M
2021-12-31-$32.89M$11,000.00-$32.9M
2020-12-31-$26.29M$44,000.00-$26.33M
2019-12-31-$14.94M$12,000.00-$14.95M
2018-12-31-$9.02M$90,000.00-$9.11M
2017-12-31-$12.07M$12,000.00-$12.08M
2016-12-31-$12.13M$17,000.00-$12.15M
2015-12-31-$8.47M$159,000.00-$8.63M
2014-12-31-$9.24M$770,000.00-$10.01M
2013-12-31-$2.52M$13,000.00-$2.54M
2012-12-31-$3.08M$32,000.00-$3.11M